Millennium Management’s Keros Therapeutics KROS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.18M | Sell |
106,858
-113,351
| -51% | -$1.75M | ﹤0.01% | 4271 |
|
|
2025
Q4 | $4.48M | Buy |
220,209
+166,863
| +313% | +$2.93M | ﹤0.01% | 3136 |
|
|
2025
Q3 | $844K | Buy |
53,346
+39,641
| +289% | +$586K | ﹤0.01% | 4747 |
|
|
2025
Q2 | $183K | Sell |
13,705
-219,498
| -94% | -$2.96M | ﹤0.01% | 5390 |
|
|
2025
Q1 | $2.38M | Sell |
233,203
-644,956
| -73% | -$7.49M | ﹤0.01% | 3617 |
|
|
2024
Q4 | $13.9M | Buy |
878,159
+305,169
| +53% | +$15.9M | 0.01% | 1854 |
|
|
2024
Q3 | $33.3M | Buy |
572,990
+180,034
| +46% | +$8.89M | 0.03% | 1120 |
|
|
2024
Q2 | $18M | Buy |
392,956
+55,293
| +16% | +$2.97M | 0.01% | 1598 |
|
|
2024
Q1 | $22.4M | Sell |
337,663
-184,465
| -35% | -$10.9M | 0.02% | 1472 |
|
|
2023
Q4 | $20.8M | Buy |
522,128
+318,071
| +156% | +$9.97M | 0.02% | 1512 |
|
|
2023
Q3 | $6.51M | Buy |
204,057
+164,161
| +411% | +$6.13M | 0.01% | 2448 |
|
|
2023
Q2 | $1.6M | Buy |
39,896
+15,523
| +64% | +$680K | ﹤0.01% | 3669 |
|
|
2023
Q1 | $1.04M | Sell |
24,373
-156,904
| -87% | -$7.92M | ﹤0.01% | 4058 |
|
|
2022
Q4 | $8.71M | Buy |
+181,277
| New | +$8.47M | 0.01% | 2286 |
|
|
2022
Q2 | – | Sell |
-65,688
| Closed | -$3.57M | – | 7300 |
|
|
2022
Q1 | $3.57M | Buy |
65,688
+12,944
| +25% | +$664K | ﹤0.01% | 3308 |
|
|
2021
Q4 | $3.09M | Sell |
52,744
-129,132
| -71% | -$6.44M | ﹤0.01% | 3353 |
|
|
2021
Q3 | $7.2M | Buy |
181,876
+64,961
| +56% | +$2.31M | 0.01% | 2448 |
|
|
2021
Q2 | $4.96M | Sell |
116,915
-13,350
| -10% | -$723K | 0.01% | 2764 |
|
|
2021
Q1 | $8.02M | Buy |
130,265
+42,309
| +48% | +$2.68M | 0.01% | 2036 |
|
|
2020
Q4 | $6.2M | Buy |
87,956
+79,217
| +906% | +$4.99M | 0.01% | 2233 |
|
|
2020
Q3 | $337 | Buy |
+8,739
| New | +$347K | ﹤0.01% | 3778 |
|
Other funds holding KROS
NCM
VCM
O
VPM
MAP